Overexpression of ADAMTS-2 in tumor cells and stroma is predictive of poor clinical prognosis in gastric cancer
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 84, 44-51
Abstract
No abstract availableKeywords
Funding Information
- Key Medical Talents (ZDRCA2016051)
- Six High Level Talents Project (LGY2016038)
- Jiangsu Health Planning Commission, Jiangsu, China, and Science and Technology Projects (MS32017001, MS12016031)
This publication has 28 references indexed in Scilit:
- Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in ChinaJournal of Translational Medicine, 2013
- Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and DirectnessPLOS ONE, 2012
- The roles of ADAMTS metalloproteinases in tumorigenesis and metastasisFrontiers in Bioscience-Landmark, 2011
- Epidemiology of Helicobacter pylori infection and gastric cancer in AsiaJournal of Gastroenterology and Hepatology, 2010
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Domains and Maturation Processes That Regulate the Activity of ADAMTS-2, a Metalloproteinase Cleaving the Aminopropeptide of Fibrillar Procollagens Types I–III and VJournal of Biological Chemistry, 2005
- X-TileClinical Cancer Research, 2004
- Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers–Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 GeneJournal of Investigative Dermatology, 2004
- Transforming Growth Factor-β Induces Secretion of Activated ADAMTS-2Journal of Biological Chemistry, 2003
- Characterization and Partial Amino Acid Sequencing of a 107-kDa Procollagen I N-Proteinase Purified by Affinity Chromatography on Immobilized Type XIV CollagenJournal of Biological Chemistry, 1995